Abstract

Lipids and especially raised low-density lipoprotein cholesterol (LDL-C) are a key contributor to cardiovascular disease risk. Genetic dyslipidaemias including familial hypercholesterolaemia are common. Statins, ezetimibe and proprotein convertase subtilisin kexin-9 (PCSK9) inhibitors treatment are effective. The role of triglyceride drugs such as fibrates and omega-3 fatty acids is less clear.

ARTICLE RESOURCES

Article PDF
Lipids measurement and management – Artcle PDF 00:00:00
CPD Assessment
Lipids: measurement and management Unlimited

Article Reviews

N.A

ratings
  • 5 stars0
  • 4 stars0
  • 3 stars0
  • 2 stars0
  • 1 stars0

No Reviews found for this Article.

3 MemberS ENROLLED

ARTICLE RESOURCES

Article PDF
Lipids measurement and management – Artcle PDF 00:00:00
CPD Assessment
Lipids: measurement and management Unlimited

Advanced Article Search

X